» Articles » PMID: 23096096

Upregulation of VEGF Expression is Associated with Accumulation of HIF-1α in the Skin of Naïve Scleroderma Patients

Overview
Journal Mod Rheumatol
Specialty Rheumatology
Date 2012 Oct 26
PMID 23096096
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic sclerosis is a disease hallmarked by microangiopathy; the enlargement and leakage of skin capillaries in active stages develops into extensive avascular areas, clinically associated with severe tissue hypoxia and the formation of digital ulcers. Vascular endothelial growth factor (VEGF) is upregulated in all stages of the disease, with little effect on efficient neovascularization. The oxygen-regulated α-subunit of hypoxia-inducible transcription factor-1 (HIF-1α) represents a key mechanism involved in the transcriptional regulation of VEGF. The aim of this study is to investigate expression of the oxygen-regulated α-subunit of HIF-1 and VEGF in naïve scleroderma patients. For this purpose, skin biopsies (dorsal hand surface) from scleroderma patients were analyzed and compared with control skin biopsies. Immunoreactivity for VEGF was enhanced in scleroderma patients, in contrast to restricted positive immunostaining in suprabasal keratinocytes observed in normal skin. In a similar fashion, all skin biopsies from scleroderma patients were strongly HIF-1α reactive, compared with rare immunoreactivity observed in normal skin. The pattern was similar in all stages of scleroderma. These observations for the first time directly connect constitutive hypoxia with VEGF upregulation in scleroderma patients. The sequence of events needs to be precisely mapped, and the pro- and antiangiogenic switches which may interfere with efficient tissue neovascularization identified, in order to provide meaningful therapeutic strategies.

Citing Articles

Use of nailfold capillaroscopy for the assessment of patients undergoing digit replantation and revascularization.

Koroglu M, Karakaplan M, Zontul S, Acet O, Ozdes H, Ergen E Jt Dis Relat Surg. 2024; 36(1):65-77.

PMID: 39719903 PMC: 11734863. DOI: 10.52312/jdrs.2025.1900.


Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis.

Maciejewska M, Sikora M, Stec A, Zaremba M, Maciejewski C, Pawlik K Dermatol Ther (Heidelb). 2023; 13(7):1549-1560.

PMID: 37316749 PMC: 10307739. DOI: 10.1007/s13555-023-00952-w.


Emerging role of hypoxia-inducible factor-1α in inflammatory autoimmune diseases: A comprehensive review.

Tang Y, Wang D, Wang Y, Huang A, Xu W Front Immunol. 2023; 13:1073971.

PMID: 36761171 PMC: 9905447. DOI: 10.3389/fimmu.2022.1073971.


The Immunogenetics of Morphea and Lichen Sclerosus.

Khan Mohammad Beigi P Adv Exp Med Biol. 2022; 1367:155-172.

PMID: 35286696 DOI: 10.1007/978-3-030-92616-8_7.


Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis.

Mao J, Liu J, Zhou M, Wang G, Xiong X, Deng Y PLoS One. 2022; 17(3):e0263369.

PMID: 35231032 PMC: 8887755. DOI: 10.1371/journal.pone.0263369.